Maze Therapeutics, Common Stock Alpha and Beta Analysis
| MAZE Stock | 42.10 0.02 0.05% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Maze Therapeutics, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Maze Therapeutics, over a specified time horizon. Remember, high Maze Therapeutics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Maze Therapeutics,'s market risk premium analysis include:
Beta 1.65 | Alpha 0.64 | Risk 3.24 | Sharpe Ratio 0.25 | Expected Return 0.82 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Maze Therapeutics, Backtesting, Maze Therapeutics, Valuation, Maze Therapeutics, Correlation, Maze Therapeutics, Hype Analysis, Maze Therapeutics, Volatility, Maze Therapeutics, History and analyze Maze Therapeutics, Performance. Maze Therapeutics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Maze Therapeutics, market risk premium is the additional return an investor will receive from holding Maze Therapeutics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Maze Therapeutics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Maze Therapeutics,'s performance over market.| α | 0.64 | β | 1.65 |
Maze Therapeutics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Maze Therapeutics,'s Buy-and-hold return. Our buy-and-hold chart shows how Maze Therapeutics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Maze Therapeutics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Maze Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Maze Therapeutics, shares will generate the highest return on investment. By understating and applying Maze Therapeutics, stock market price indicators, traders can identify Maze Therapeutics, position entry and exit signals to maximize returns.
Maze Therapeutics, Return and Market Media
The median price of Maze Therapeutics, for the period between Tue, Sep 30, 2025 and Mon, Dec 29, 2025 is 32.53 with a coefficient of variation of 16.16. The daily time series for the period is distributed with a sample standard deviation of 5.41, arithmetic mean of 33.46, and mean deviation of 4.72. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Insider Trading | 10/06/2025 |
2 | Maze Achieves Shopify Premier Partner Status, Expanding Support for Enterprise Brands Ready to GetUnstuck | 10/09/2025 |
3 | Disposition of 28423 shares by Homcy Charles J of Maze Therapeutics, subject to Rule 16b-3 | 10/23/2025 |
4 | Maze Therapeutics Hits New 12-Month High - Should You Buy - MarketBeat | 10/29/2025 |
5 | Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week | 11/06/2025 |
6 | Evaluating Maze Therapeutics Is the Current Valuation Justified After Recent Volatility | 11/11/2025 |
7 | Acquisition by Homcy Charles J of 1489 shares of Maze Therapeutics, subject to Rule 16b-3 | 11/19/2025 |
8 | Maze Therapeutics Stock Price Up 8.4 percent - Should You Buy - MarketBeat | 11/20/2025 |
9 | Were Not Worried About Maze Therapeutics Cash Burn | 12/15/2025 |
About Maze Therapeutics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Maze or other stocks. Alpha measures the amount that position in Maze Therapeutics, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | PB Ratio | 6.88 | 69.45 | 3.55 | Capex To Depreciation | 0.51 | 0.11 | 0.35 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Maze Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Maze Therapeutics,'s short interest history, or implied volatility extrapolated from Maze Therapeutics, options trading.
Build Portfolio with Maze Therapeutics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Maze Therapeutics, Backtesting, Maze Therapeutics, Valuation, Maze Therapeutics, Correlation, Maze Therapeutics, Hype Analysis, Maze Therapeutics, Volatility, Maze Therapeutics, History and analyze Maze Therapeutics, Performance. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Maze Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.